Home  /  Resource Library  /  Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents

Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents

Study investigated outcomes of patients with Hodgkin lymphoma treated with autologous stem cell transplant.